TY - JOUR
T1 - In vitro fertilization and risk of childhood leukemia in Greece and Sweden
AU - Petridou, Eleni Th
AU - Sergentanis, Theodoros N.
AU - Panagopoulou, Paraskevi
AU - Moschovi, Maria
AU - Polychronopoulou, Sophia
AU - Baka, Margarita
AU - Pourtsidis, Apostolos
AU - Athanassiadou, Fani
AU - Kalmanti, Maria
AU - Sidi, Vasiliki
AU - Dessypris, Nick
AU - Frangakis, Constantine
AU - Matsoukis, Ioannis L.
AU - Stefanadis, Christodoulos
AU - Skalkidou, Alkistis
AU - Stephansson, Olof
AU - Adami, Hans Olov
AU - Kieler, Helle
PY - 2012/6
Y1 - 2012/6
N2 - Background: Cancer risk in children born after in vitro fertilization (IVF) remains largely unknown. We aimed to investigate risk of leukemia and lymphoma following IVF using two nationwide datasets. Methods: The hospital-based case-control study in Greece derived from the National Registry for Childhood Hematological Malignancies (1996-2008, 814 leukemia and 277 lymphoma incident cases with their 1:1 matched controls). The Swedish case-control study was nested in the Swedish Medical Birth Register (MBR) (1995-2007, 520 leukemia and 71 lymphoma cases with their 5,200 and 710 matched controls) with ascertainment of incident cancer cases in the National Cancer Register. Study-specific and combined odds ratios (OR) were estimated using conditional logistic regression, with adjustment for possible risk factors. Results: Nationwide studies pointed to similar size excess risk of leukemia following IVF, but to a null association between IVF and lymphoma. The proportion of leukemia cases conceived through IVF was 3% in Greece and 2.7% in Sweden; prevalence of IVF in matched controls was 1.8% and 1.6%, respectively. In combined multivariable analyses, the increased risk of leukemia was confined to age below 3.8 years (OR=2.21; 95% confidence interval, CI: 1.27-3.85) and to acute lymphoblastic leukemia (ALL) (OR=1.77; 95% CI: 1.06-2.95) with no sufficient evidence of excess risk for other leukemias (OR=1.34; 95% CI: 0.38-4.69). Following IVF, OR for ALL was 2.58 (95% CI: 1.37-4.84) before age 3.8 and 4.29 (95% CI: 1.49-12.37) before age 2 years. Conclusions: IVF seems to be associated with increased risk of early onset ALL in the offspring.
AB - Background: Cancer risk in children born after in vitro fertilization (IVF) remains largely unknown. We aimed to investigate risk of leukemia and lymphoma following IVF using two nationwide datasets. Methods: The hospital-based case-control study in Greece derived from the National Registry for Childhood Hematological Malignancies (1996-2008, 814 leukemia and 277 lymphoma incident cases with their 1:1 matched controls). The Swedish case-control study was nested in the Swedish Medical Birth Register (MBR) (1995-2007, 520 leukemia and 71 lymphoma cases with their 5,200 and 710 matched controls) with ascertainment of incident cancer cases in the National Cancer Register. Study-specific and combined odds ratios (OR) were estimated using conditional logistic regression, with adjustment for possible risk factors. Results: Nationwide studies pointed to similar size excess risk of leukemia following IVF, but to a null association between IVF and lymphoma. The proportion of leukemia cases conceived through IVF was 3% in Greece and 2.7% in Sweden; prevalence of IVF in matched controls was 1.8% and 1.6%, respectively. In combined multivariable analyses, the increased risk of leukemia was confined to age below 3.8 years (OR=2.21; 95% confidence interval, CI: 1.27-3.85) and to acute lymphoblastic leukemia (ALL) (OR=1.77; 95% CI: 1.06-2.95) with no sufficient evidence of excess risk for other leukemias (OR=1.34; 95% CI: 0.38-4.69). Following IVF, OR for ALL was 2.58 (95% CI: 1.37-4.84) before age 3.8 and 4.29 (95% CI: 1.49-12.37) before age 2 years. Conclusions: IVF seems to be associated with increased risk of early onset ALL in the offspring.
KW - Acute lymphoblastic leukemia
KW - Assisted reproductive technologies
KW - Childhood cancer
KW - Risk factor
UR - http://www.scopus.com/inward/record.url?scp=84855818606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84855818606&partnerID=8YFLogxK
U2 - 10.1002/pbc.23194
DO - 10.1002/pbc.23194
M3 - Article
C2 - 21618418
AN - SCOPUS:84855818606
SN - 1545-5009
VL - 58
SP - 930
EP - 936
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 6
ER -